Phenotypeca engages grant writing specialist, Dr Emma Richardson, to lead a non-dilutive funding strategy at the end of August
We are delighted to announce that Dr Emma Richardson has joined our team to support us to win grant funding from non-dilutive sources starting on 24th August.
Emma is a grant writing specialist who is highly proficient in innovation management and grant writing, having prepared over 100 funding applications for R&D firms in the Life Science, Medical Device, and Biotechnology sectors, from a range UK and EU funders.
Grant funding is a significant income source for Phenotypeca’s platform development until it is ready for commercial launch in 2021.
Emma has a 1st Class Molecular Biology and Biochemistry BSc from Durham University, and a PhD in RNA Biology from the University of Nottingham. She has spent the past seven years as a business consultant specialising in grant funding support for innovative companies of all sizes.